Similar articles

• HIV-1/AIDS vaccine development: are we in the darkness.

  Qiu C, Xu JQ. Qiu C, et al. Chin Med J (Engl). 2008 May 20;121(10):939-45. Chin Med J (Engl). 2008. PMID: 18706210 Review. No abstract available.
• [HIV/AIDS infection. The Brazilian view. AIDS in Brazil].

  Gonçalves AP, De Sa CA, Rubini N. Gonçalves AP, et al. An R Acad Nac Med (Madr). 1996;Spec No:145-56. An R Acad Nac Med (Madr). 1996. PMID: 8815731 Portuguese.
• HIV infection and AIDS among drug injectors at Rio de Janeiro: perspectives and unanswered questions.

  Lima ES, Bastos FI, Telles PR, Friedman SR. Lima ES, et al. Bull Narc. 1993;45(1):107-15. Bull Narc. 1993. PMID: 8305901 Review.
• Thorny issues in the ethics of AIDS vaccine trials.

  Berkley S. Berkley S. Lancet. 2003 Sep 20;362(9388):992. doi: 10.1016/S0140-6736(03)14371-1. Lancet. 2003. PMID: 14513850 No abstract available.
• Is there any room for therapeutic vaccination against the HIV-1/AIDS?

  Iglesias E. Iglesias E. Hum Vaccin Immunother. 2013 Jul;9(7):1539-44. doi: 10.4161/hv.24405. Epub 2013 Apr 9. Hum Vaccin Immunother. 2013. PMID: 23571171